Stephen E. Gitelman, MD, is Professor of Clinical Pediatrics at the University of California School of Medicine in San Francisco, California. He is Chief of the Pediatric Endocrinology and Diabetes Division, and holds the Mary B. Olney, MD / KAK Distinguished Chair in Pediatric Diabetes and Clinical Research.  He is an active member of the Madison clinical care team, but also spends a great deal of his time as a clinical and translational researcher.  He is  primarily involved in clinical trials with immuno-therapies to alter the natural course of type 1 diabetes—studies to screen and predict risk for diabetes; to prevent diabetes from occurring in those found to be at risk; to preserve insulin producing beta cell function in those with recent onset disease; and to replace beta cells in those with long-standing disease. 

Dr. Gitelman received his undergraduate degree from Princeton University, and medical degree from the University of North Carolina at Chapel Hill.  He then headed west, completing pediatric residency and pediatric endocrinology fellowship training at the University of California at San Francisco before joining the faculty in 1990.